Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index; 41 of the 102 sources its claims cite were checked for support.

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

Open access
Einarson, Thomas R., Acs, Annabel, Ludwig, Craig, Panton, Ulrik H. · 2018 · Cardiovascular Diabetology

Abstract

BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes (T2DM). CVD's prevalence has been growing over time. PURPOSE: To estimate the current prevalence of CVD among adults with T2DM by reviewing literature published within the last 10 years (2007-March 2017). METHODS: We searched Medline, Embase, and proceedings of major scientific meetings for original research documenting the prevalence of CVD in T2DM. CVD included stroke, myocardial infarction, angina pectoris, heart failure, ischemic heart disease, cardiovascular disease, coronary heart disease, atherosclerosis, and cardiovascular death. No restrictions were placed on country of origin or publication language. Two reviewers independently searched for articles and extracted data, adjudicating results through consensus. Data were summarized descriptively. Risk of bias was examined by applying the STROBE checklist. RESULTS: We analyzed data from 57 articles with 4,549,481 persons having T2DM. Europe produced the most articles (46%), followed by the Western Pacific/China (21%), and North America (13%). Overall in 4,549,481 persons with T2DM, 52.0% were male, 47.0% were obese, aged 63.6 ± 6.9 years old, with T2DM duration of 10.4 ± 3.7 years. CVD affected 32.2% overall (53 studies, N = 4,289,140); 29.1% had atherosclerosis (4 studies, N = 1153), 21.2% had coronary heart disease (42 articles, N = 3,833,200), 14.9% heart failure (14 studies, N = 601,154), 14.6% angina (4 studies, N = 354,743), 10.0% myocardial infarction (13 studies, N = 3,518,833) and 7.6% stroke (39 studies, N = 3,901,505). CVD was the cause of death in 9.9% of T2DM patients (representing 50.3% of all deaths). Risk of bias was low; 80 ± 12% of STROBE checklist items were adequately addressed. CONCLUSIONS: Globally, overall CVD affects approximately 32.2% of all persons with T2DM. CVD is a major cause of mortality among people with T2DM, accounting for approximately half of all deaths over the study period. Coronary artery disease and stroke were the major contributors.

Overview

CoChat Summary

TL;DR

This systematic review estimated global cardiovascular disease (CVD) prevalence among adults with type 2 diabetes (T2DM) from 57 articles covering 4,549,481 persons published 2007–March 2017. Overall CVD prevalence was 32.2%, and CVD accounted for 50.3% of all deaths in T2DM patients.

Key findings

  • Among 4,549,481 persons with T2DM, overall CVD prevalence was 32.2% (53 studies, N = 4,289,140); coronary artery disease was 21.2% (42 studies, N = 3,833,200), atherosclerosis 29.1% (4 studies, N = 1,153), heart failure 14.9% (14 studies, N = 601,154), angina 14.6% (4 studies, N = 354,743), myocardial infarction 10.0% (13 studies, N = 3,518,833), and stroke 7.6% (39 studies, N = 3,901,505).
  • CVD was the cause of death in 9.9% of T2DM patients (8 studies, N = 3,208,557) and represented 50.3% of all deaths (7 studies, N = 86,557); CAD deaths were 6.3% and cerebrovascular deaths 1.5%.
  • Regional overall CVD prevalence was highest in North America/Caribbean (46.0%), Southeast Asia (42.5%), and Western Pacific/China (33.6%); Europe produced the most articles (46%).
  • Males had higher prevalence than females for all outcomes except overall CVD, where both sexes had approximately 27%; five papers found a positive relationship between obesity and CVD, e.g., heart failure prevalence was 38.7% with BMI ≥ 30 kg/m² versus 23.4% with BMI < 30 kg/m².

Methods

  • Systematic literature review following PRISMA; searched Medline, Embase, PubMed ahead-of-print, and proceedings of ISPOR, ADA, EASD, and AACE for original research published January 2007–March 2017, with no country or language restrictions; two reviewers independently searched and extracted data, with a third reviewer for quality assurance.
  • Included adults ≥ 18 years with T2DM; eligible designs were prevalence studies, cross-sectional surveys, database studies, or chart reviews, with incidence studies accepted only if they provided population-based baseline and follow-up data; excluded clinical trial programs or individual pharmaceutical product studies and certain CVDs such as peripheral artery disease, rheumatic heart disease, dysrhythmias, and CABG/revascularization.
  • Data were summarized descriptively with sums, averages, medians, and ranges; weighted averages were calculated for countries and IDF regions; risk of bias was assessed with the STROBE checklist; 57 articles (60 analyses) with 4,549,481 persons were included.

Limitations

  • Stated by the authors: limited by available literature and article validity/quality; some results appeared only as abstracts with space limitations; incomplete or selective outcome reporting; restricted to adults ≥ 18 and T2DM only; inconsistent CVD definitions and varied outcomes across studies; prevalence studies only; varied data collection methods and time periods; possible overestimation due to sicker clinical populations and inclusion of patients with existing CVD; only 25 countries represented, with little from Africa, the Asian subcontinent, or Latin America.
  • Evident in the text: no overall quantitative synthesis or meta-analysis was undertaken; one Russian study of 3,060,517 patients skewed weighted averages, so the authors calculated weighted averages with and without that study; prevalence estimates were based only on studies reporting each outcome, which may represent subgroups and may underestimate some outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12933-018-0728-6

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flowchart of article selection. The flowchart depicts the article selection process
Fig. 1 Flowchart of article selection. The flowchart depicts the article selection processCC BY · PubMed Central
Fig. 2 Distribution of studies across countries and regions. The figure illustrates the global distribution of studies across countries and regions
Fig. 2 Distribution of studies across countries and regions. The figure illustrates the global distribution of studies across countries and regionsCC BY · PubMed Central

Verification

Claims the paper makes

32 Valid · 1 Not valid · 37 Not checked · 73 Own results and interpretations

73 more claims · 25 with their cited sources checked

Create a free account to see all 143 claims and to verify the 61 references still open.

See all claims — free account
  • Probably not a substantial claim. 35
  • It may state two separate claims as one. 34
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 7 · the rest aren’t loaded

2 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 124 references

Research works printed but not linked: 5

  1. International Diabetes Federation. idf diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2015.
  2. Shestakova M: Dynamics in prevalence of diabetes, diabetic complications and quality of diabetes care in Russian Federation in 2014–2015 by data of national diabetes register. In: Conference: 52nd annual meeting of the european association for the study of diabetes, EASD. 2016. p. 309.
  3. World Health Organization. Obesity and Overweight. Factsheet No 311. Geneva: World Health Organization; 2017.
  4. Cortez-Dias N, Martins S, Belo A, Fiuza M. em nome dos Investigadores do Estudio VALSIM: prevalência, tratamento e controlo da diabetes mellitus e dos factores de risco associados nos cuidados de saúde primários em Portugal. Rev Port Cardiol. 2010;29:509–37.
  5. Kwon H, Lim J, Shin J, Son J, Lee S, Kim S, Yoo S. A relationship of asymptomatic coronary artery disease and type 2 diabetes in acute ischaemic stroke patients; cerebral angiography and coronary angiography study. Diabetoligia. 2014;57:S26.

Cited by

See all 2,312

Metadata

Authors
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H.
Affiliations
  • University of Toronto (CA)
  • Novo Nordisk (Denmark) (DK)
Corresponding author
Ludwig, Craig
Venue
Cardiovascular Diabetology
Published
2018-06-08
Volume
17
Issue
1
Pages
83-83
ISSN
1475-2840 (ISSN-L)
OpenAlex
W2806521060
Cited by
2,312
References
124
Citations by year
2026: 191 · 2025: 345 · 2024: 432 · 2023: 344 · 2022: 391 · 2021: 291 · 2020: 217 · 2019: 92 · 2018: 5
FWCI
23.31
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Novo Nordisk
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
cardiovascular disease, type 2 diabetes, prevalence, coronary artery disease, heart failure, stroke, myocardial infarction, angina pectoris, cardiovascular mortality, atherosclerosis, comorbidities
MeSH terms
Adult, Aged, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Prognosis, Risk Factors, Time Factors, Global Health, Comorbidity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. https://app.cochat.ai/papers/10.1186/s12933-018-0728-6
The paper
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018). Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-018-0728-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.